2018 Archives
You are viewing archived information from 2018
Measure Title: |
RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS.
|
Report Title: |
Terminally Ill Patients; Investigational Drugs; Biological Products
|
Description: |
Permits manufacturers of investigational drugs or biological products beginning on January 1, 2018 to make these drugs and products available to terminally ill patients under certain conditions, including while pending participation in the federal expanded access program.
|
Companion: |
|
Package: |
None
|
Current Referral: |
CPH, JDC
|
Introducer(s): |
ESPERO, HARIMOTO, K. RHOADS, S. Chang
|
Act: |
|
Sort by Date | | Status Text |
1/17/2018 | S | Re-Referred to CPH, JDC. |
11/30/2017 | D | Carried over to 2018 Regular Session. |
1/27/2017 | S | Referred to CPH, JDL. |
1/25/2017 | S | Passed First Reading. |
1/25/2017 | S | Introduced. |
S = Senate |
H = House |
D = Data Systems |
$ = Appropriation measure |
ConAm = Constitutional Amendment
Some of the above items require Adobe Acrobat Reader. Please visit
Adobe's download page
for detailed instructions.
SB1110
No other committee reports available at this time.
You may search in our Document Directories if you believe this message is in error. The link is on the home page under Search.
No testimony available at this time.